Pro Medicus Limited

ASX (AUD): Pro Medicus Limited (PME)

Last Price

139.64

Today's Change

-3.36 (2.34%)

Day's Change

136.60 - 143.67

Trading Volume

435,980

Overview

Market Cap

14 Billion

Shares Outstanding

104 Million

Avg Volume

366,939

Avg Price (50 Days)

118.67

Avg Price (200 Days)

99.28

PE Ratio

208.42

EPS

0.67

Earnings Announcement

13-Aug-2024

Previous Close

143.00

Open

142.93

Day's Range

136.6 - 143.67

Year Range

61.95 - 143.67

Trading Volume

435,980

Price Change Highlight

1 Day Change

-2.35%

5 Day Change

1.93%

1 Month Change

20.69%

3 Month Change

38.71%

6 Month Change

46.05%

Ytd Change

45.01%

1 Year Change

113.32%

3 Year Change

144.98%

5 Year Change

441.24%

10 Year Change

16137.21%

Max Change

12042.61%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Health Information Services

Description:

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment